A Double Blind Clinical Trial of DCS for Food Anxiety
| Status: | Completed |
|---|---|
| Conditions: | Anxiety, Psychiatric, Psychiatric, Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 14 - 65 |
| Updated: | 4/17/2018 |
| Start Date: | February 2013 |
| End Date: | February 2014 |
A Double Blind Clinical Trial of DCS for Food Anxiety for Patients With Anorexia and Bulimia Nervosa
This is a pilot study investigating if cycloserine (DCS; a learning enhancement medication)
augments exposure therapy for food anxiety in patients with anorexia and bulimia nervosa. The
investigators expect that (a) exposure therapy will reduce anxiety (b) anxiety will be
reduced more in the DCS relative to placebo condition (c) participants in the DCS condition
will have a greater increase in Body Mass Index.
augments exposure therapy for food anxiety in patients with anorexia and bulimia nervosa. The
investigators expect that (a) exposure therapy will reduce anxiety (b) anxiety will be
reduced more in the DCS relative to placebo condition (c) participants in the DCS condition
will have a greater increase in Body Mass Index.
This study investigated if DCS vs placebo augmented food exposure in individuals with eating
disorders.
disorders.
Inclusion Criteria:
- Diagnosed with Anorexia Nervosa, Bulimia Nervosa, Eating Disorder Not Otherwise
Specified
Exclusion Criteria:
- Pregnant or planning on becoming pregnant
- Psychotic or Manic
We found this trial at
1
site
Click here to add this to my saved trials
